Recently added

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Sanchez Mauriño, Pedro; Serrano Domingo, Juan Jose; García Galindo , Regina; Sequero-Lopez, Silvia; Gutierrez Sanz, Lourdes; SORIA RIVAS, AINARA; MUÑOZ COUSELO, EVA (Frontiers Media, 2025-02-26)

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data

SABATE, Jean-Marc; Beato-Zambrano, Carmen; lemaire, antoine; Montesarchio, Vincenzo; Serna Mont-Ros, Judith; cobo, manuel (MDPI, 2025-03)

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Park, Yeon Hee; Sohn, Joohyuk; Cortes, Javier; MUÑOZ COUSELO, EVA; Kim, Sung-Bae; Dent, Rebecca (BMC, 2025-03-11)

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study

Tapia Céspedes, Marta; Marín-Aguilera, Mercedes; Hernández-Illán, Eva; Tébar, C.; Martínez-Puchol, Ana Isabel; Martínez-Sáez, Olga; Villacampa Javierre, Guillermo; Rezqallah Arón , María Alejandra; Saura Manich, Cristina; Escriva de Romani, Santiago (Elsevier, 2025-06)

SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer

Novikov, Dmitry; Grigoriou, Athanasios; Bernatowicz, Kinga; Simonetti, Sara; Serna, Garazi; Roson Gradaille, Nuria; ESCOBAR, MANUEL; Vieito , Maria; Nuciforo, Paolo; Toledo, Rodrigo; GARRALDA, Elena; Perez-Lopez, Raquel; Grussu, Francesco (Elsevier, 2025-05)

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study

SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer

Scientia. Dipòsit d'Informació Digital del Departament de Salut

Vall d'Hebron Institut d'Oncologia - VHIO: Recent submissions

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial ﻿

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data ﻿

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study ﻿

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study ﻿

SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer ﻿

Real-life evidence of encorafenib plus binimetinib in patients with unresectable advanced or metastatic BRAFV600-mutant melanoma in Spain: the BECARE (GEM-2002) trial

Naloxegol for the Treatment of Opioid-Induced Constipation in Patients with Cancer Pain: A Pooled Analysis of Real-World Data

Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study

Clinical decision impact of HER2DX, an algorithm-powered genomic diagnostic in early-stage HER2-positive breast cancer: results from a prospective real-world study

SpinFlowSim: A blood flow simulation framework for histology-informed diffusion MRI microvasculature mapping in cancer